Cognitive impairment in schizophrenia

characteristics, assessment, and treatment

Verfasser / Beitragende:
ed. by Philip D. Harvey
Ort, Verlag, Jahr:
Cambridge : Cambridge University Press, 2013
Beschreibung:
XV, 324 p. : ill.
Format:
Buch
ID: 278731147
LEADER cam a22 4 4500
001 278731147
003 CHVBK
005 20200107140226.0
008 130818s2013 xxk 00 eng|d
010 |a  2012024803 
015 |a GBB2-91489  |2 bnb 
020 |a 1-107-01320-8  |q hbk 
020 |a 978-1-107-01320-9 
035 |a (IDSBB)006088839 
035 |a (NEBIS)007297507 
035 |a (IDSSG)000840939 
035 |a (OCoLC)821854492 
040 |a NLGGC  |d SzZuIDS BS/BE B542  |e kids 
082 0 |a 616.898  |2 23 
084 |a 44.91  |2 bcl 
245 0 0 |a Cognitive impairment in schizophrenia  |b characteristics, assessment, and treatment  |c ed. by Philip D. Harvey 
264 1 |a Cambridge  |b Cambridge University Press  |c 2013 
300 |a XV, 324 p.  |b ill. 
500 |a Cambridge medicine 
520 3 |a Although the precise mechanisms and pathways of schizophrenia remain something of a mystery, there is little dispute that cognitive deficits present as some of the clearest and most debilitating symptoms of the disease. This book describes the characteristics of cognitive deficits in schizophrenia, functional implications, the course of impairments, the genetic and biological contributions and reviews management options, including neuropsychological, psychological and pharmacological techniques. Chapters are written by leading experts in the field, in an accessible and highly informative style, ensuring the content is clinically relevant. State-of-the-art information about new developments in the treatment of related features of the illness, such as disability, is provided. The wide ranging focus of this volume will appeal to clinicians and academic researchers working with patients impaired by severe mental illness. 
650 0 |a Schizophrenia 
650 0 |a Cognition disorders 
650 0 |a Cognition disorders  |x Treatment 
650 7 |a Cognitieve stoornissen  |2 gtt 
650 7 |a Schizofrenie  |2 gtt 
650 7 |a Schizophrenie  |0 (DE-588)4052527-2  |2 gnd 
650 7 |a Kognitive Störung  |0 (DE-588)4164473-6  |2 gnd 
650 7 |a Genetik  |0 (DE-588)4071711-2  |2 gnd 
650 7 |a Therapie  |0 (DE-588)4059798-2  |2 gnd 
650 7 |a Kognition  |0 (DE-588)4031630-0  |2 gnd 
655 7 |a Aufsatzsammlung  |2 gnd 
655 7 |a Aufsatzsammlung  |2 gnd-content 
700 1 |a Harvey  |D Philip D. 
909 7 |a zbzmon201305f  |c proc  |d zbzswk201306b  |e baie  |2 idszbz Z2 
912 7 |a ZB153  |2 Z01 
912 7 |a ZB157  |2 Z01 
950 |B IDSBB  |P 700  |E 1-  |a Harvey  |D Philip D. 
950 |B NEBIS  |P 700  |E 1-  |a Harvey  |D Philip D. 
950 |B IDSSG  |P 100  |E 1-  |a Harvey  |D Philip D. 
986 |a SWISSBIB  |b 278731147 
898 |a BK020000  |b XK020000  |c XK020000 
956 4 |B NEBIS  |C ZAD50  |u https://opac.nebis.ch/objects/pdf03/z01_978-1-107-01320-9_01.pdf  |y Titelblatt und Inhaltsverzeichnis  |x VIEW  |q pdf 
949 |B IDSBB  |F A206  |b A206  |c 206KP  |j PSY KPE/KPP 939  |x NELA2061907  |y Thea Zander-Schellenberg 
949 |B IDSBB  |F B542  |b B542  |c FH  |j PW 33.2013.1  |x NELB5421303